These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 11440386

  • 1. Clinical relevance of CagA-specific antibodies related to CagA status of Helicobacter pylori isolates using immunofluorescence test and PCR.
    Krausse R, Garten L, Harder T, Ullmann U, Birkner T, Doniec M, Grimm H.
    Infection; 2001; 29(3):154-8. PubMed ID: 11440386
    [Abstract] [Full Text] [Related]

  • 2. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
    Lamarque D, Gilbert T, Roudot-Thoraval F, Deforges L, Chaumette MT, Delchier JC.
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
    [Abstract] [Full Text] [Related]

  • 3. Antigenic diversity and serotypes of Helicobacter pylori associated with peptic ulcer diseases.
    Park SM, Hong SI, Jung HY, Yang SK, Kim HR, Min YI, Hong WS.
    Korean J Intern Med; 1998 Jul; 13(2):104-9. PubMed ID: 9735665
    [Abstract] [Full Text] [Related]

  • 4. Presence of the cagA gene in the majority of Helicobacter pylori strains is independent of whether the individual has duodenal ulcer or asymptomatic gastritis.
    Go MF, Graham DY.
    Helicobacter; 1996 Jun; 1(2):107-11. PubMed ID: 9398887
    [Abstract] [Full Text] [Related]

  • 5. Serologic detection of infection with cagA+ Helicobacter pylori strains.
    Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, Perez-Perez GI, Blaser MJ.
    J Clin Microbiol; 1995 Jun; 33(6):1496-500. PubMed ID: 7650174
    [Abstract] [Full Text] [Related]

  • 6. CagA antibodies as a marker of virulence in chilean patients with Helicobacter pylori infection.
    Harris PR, Godoy A, Arenillas S, Riera F, García D, Einisman H, Peña A, Rollán A, Duarte I, Guiraldes E, Perez-Perez G.
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):596-602. PubMed ID: 14581804
    [Abstract] [Full Text] [Related]

  • 7. Serologic detection of Helicobacter pylori infection with cagA-positive strains in duodenal ulcer, gastric cancer, and asymptomatic gastritis.
    Miehlke S, Go MF, Kim JG, Graham DY, Figura N.
    J Gastroenterol; 1998 Nov; 33 Suppl 10():18-21. PubMed ID: 9840011
    [Abstract] [Full Text] [Related]

  • 8. Antigenic proteins of Helicobacter pylori of potential diagnostic value.
    Khalilpour A, Santhanam A, Wei LC, Saadatnia G, Velusamy N, Osman S, Mohamad AM, Noordin R.
    Asian Pac J Cancer Prev; 2013 Nov; 14(3):1635-42. PubMed ID: 23679248
    [Abstract] [Full Text] [Related]

  • 9. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis.
    Warburton VJ, Everett S, Mapstone NP, Axon AT, Hawkey P, Dixon MF.
    J Clin Pathol; 1998 Jan; 51(1):55-61. PubMed ID: 9577374
    [Abstract] [Full Text] [Related]

  • 10. Detection and typing of the virulence determinants cagA and vacA of Helicobacter pylori directly from biopsy DNA: are in vitro strains representative of in vivo strains?
    Gunn MC, Stephens JC, Stewart JD, Rathbone BJ.
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):683-7. PubMed ID: 9744698
    [Abstract] [Full Text] [Related]

  • 11. Genotyping of Helicobacter pylori strains from gastric biopsies by multiplex polymerase chain reaction. How advantageous is it?
    Bolek BK, Salih BA, Sander E.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):67-70. PubMed ID: 17300903
    [Abstract] [Full Text] [Related]

  • 12. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.
    Graham DY, Genta RM, Graham DP, Crabtree JE.
    J Clin Pathol; 1996 Oct; 49(10):829-32. PubMed ID: 8943750
    [Abstract] [Full Text] [Related]

  • 13. IgG subclass response to Helicobacter pylori and CagA antigens in children.
    Dzierzanowska-Fangrat K, Raeiszadeh M, Dzierzanowska D, Gladkowska-Dura M, Celinska-Cedro D, Crabtree JE.
    Clin Exp Immunol; 2003 Dec; 134(3):442-6. PubMed ID: 14632749
    [Abstract] [Full Text] [Related]

  • 14. [Helicobacter pylori population characteristic in patients with diseases of gastrointestinal tract].
    Zhebrun AB, Svarval' AV, Balabash OA, Ferman RS.
    Zh Mikrobiol Epidemiol Immunobiol; 2013 Dec; (2):90-6. PubMed ID: 23805678
    [Abstract] [Full Text] [Related]

  • 15. Inducible nitric oxide synthase expression in gastroduodenal diseases infected with Helicobacter pylori.
    Son HJ, Rhee JC, Park DI, Kim YH, Rhee PL, Koh KC, Paik SW, Choi KW, Kim JJ.
    Helicobacter; 2001 Mar; 6(1):37-43. PubMed ID: 11328364
    [Abstract] [Full Text] [Related]

  • 16. [Helicobacter pylori CagA antigen antibodies].
    Havlasová J, Bures J, Rejchrt S, Voxová B, Krejsek J.
    Cas Lek Cesk; 1998 Jun 29; 137(13):404-9. PubMed ID: 9748734
    [Abstract] [Full Text] [Related]

  • 17. Detection of Helicobacter pylori DNA in gastric juice by the polymerase chain reaction: comparison with findings in bacterial culture and the detection of tissue IgA and serum IgG antibodies against Helicobacter pylori.
    Matsukura N, Onda M, Tokunaga A, Kato S, Yamashita K, Ohbayashi M.
    J Gastroenterol; 1995 Dec 29; 30(6):689-95. PubMed ID: 8963384
    [Abstract] [Full Text] [Related]

  • 18. Serum antibodies positivity to 12 Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases--cross-sectional study.
    Filipec Kanizaj T, Katicić M, Presecki V, Gasparov S, Colić Cvrlje V, Kolarić B, Mrzljak A.
    Croat Med J; 2009 Apr 29; 50(2):124-32. PubMed ID: 19399945
    [Abstract] [Full Text] [Related]

  • 19. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.
    Sezikli M, Guliter S, Apan TZ, Aksoy A, Keles H, Ozkurt ZN.
    Int J Clin Pract; 2006 Oct 29; 60(10):1239-43. PubMed ID: 16669834
    [Abstract] [Full Text] [Related]

  • 20. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
    Aydın EM, Demir TD, Seymen N, Said SS, Oktem-Okullu S, Tiftikci A, Cicek B, Tokat F, Tozun N, Ince U, Sezerman U, Sayi-Yazgan A.
    Immunol Lett; 2021 Nov 29; 239():1-11. PubMed ID: 34363898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.